InvestorsHub Logo
Followers 0
Posts 538
Boards Moderated 0
Alias Born 07/16/2006

Re: nferna post# 11485

Wednesday, 12/16/2020 11:25:04 PM

Wednesday, December 16, 2020 11:25:04 PM

Post# of 17530
ITRM = Well, if it doesn't work at least they have a patent

Interum Therapeutics announces filing of U.S. patent application

Iterum Therapeutics announced the filing of a U.S. national phase patent application directed to the composition of the bilayer tablet of sulopenem etzadroxil and probenecid and its related uses with the U.S. Patent and Trademark Office. The sulopenem bilayer tablet contains sulopenem etzadroxil, a prodrug of sulopenem that enables oral bioavailability, and probenecid, a renal tubular transport blocking agent, which together enhance the exposure of sulopenem to the bacterial pathogen responsible for the infection. These claims encompass the oral formulation used in the Phase 3 registration studies to support the safety and efficacy of sulopenem etzadroxil and probenecid. An extension of the life of the patent estate would enable pursuit of claims related to our previously granted QIDP indications such as pneumonia.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News